{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T05:12:33Z","timestamp":1762060353038,"version":"build-2065373602"},"reference-count":104,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T00:00:00Z","timestamp":1659398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"FOUNDATION FOR SCIENCE AND TECHNOLOGY (FCT), Portugal","doi-asserted-by":"publisher","award":["UID\/NEU\/04539\/2019","UIDB\/04539\/2020","UIDP\/04539\/2020","POCI-01-0145-FEDER-007440","SFRH\/BD\/116794\/2016","SFRH\/BD\/136973\/2018","2020.07672.BD","2021.05543.BD"],"award-info":[{"award-number":["UID\/NEU\/04539\/2019","UIDB\/04539\/2020","UIDP\/04539\/2020","POCI-01-0145-FEDER-007440","SFRH\/BD\/116794\/2016","SFRH\/BD\/136973\/2018","2020.07672.BD","2021.05543.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COMPETE-FEDER","award":["UID\/NEU\/04539\/2019","UIDB\/04539\/2020","UIDP\/04539\/2020","POCI-01-0145-FEDER-007440","SFRH\/BD\/116794\/2016","SFRH\/BD\/136973\/2018","2020.07672.BD","2021.05543.BD"],"award-info":[{"award-number":["UID\/NEU\/04539\/2019","UIDB\/04539\/2020","UIDP\/04539\/2020","POCI-01-0145-FEDER-007440","SFRH\/BD\/116794\/2016","SFRH\/BD\/136973\/2018","2020.07672.BD","2021.05543.BD"]}]},{"DOI":"10.13039\/501100001871","name":"FCT and European Social Funding","doi-asserted-by":"publisher","award":["UID\/NEU\/04539\/2019","UIDB\/04539\/2020","UIDP\/04539\/2020","POCI-01-0145-FEDER-007440","SFRH\/BD\/116794\/2016","SFRH\/BD\/136973\/2018","2020.07672.BD","2021.05543.BD"],"award-info":[{"award-number":["UID\/NEU\/04539\/2019","UIDB\/04539\/2020","UIDP\/04539\/2020","POCI-01-0145-FEDER-007440","SFRH\/BD\/116794\/2016","SFRH\/BD\/136973\/2018","2020.07672.BD","2021.05543.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The increasing cancer incidence has certified oncological management as one of the most critical challenges for the coming decades. New anticancer strategies are still needed, despite the significant advances brought to the forefront in the last decades. The most recent, promising therapeutic approaches have benefitted from the application of human perinatal derivatives (PnD), biological mediators with proven benefits in several fields beyond oncology. To elucidate preclinical results and clinic outcomes achieved in the oncological field, we present a narrative review of the studies resorting to animal models to assess specific outcomes of PnD products. Recent preclinical evidence points to promising anticancer effects offered by PnD mediators isolated from the placenta, amniotic membrane, amniotic fluid, and umbilical cord. Described effects include tumorigenesis prevention, uncontrolled growth or regrowth inhibition, tumor homing ability, and adequate cell-based delivery capacity. Furthermore, PnD treatments have been described as supportive of chemotherapy and radiological therapies, particularly when resistance has been reported. However, opposite effects of PnD products have also been observed, offering support and trophic effect to malignant cells. Such paradoxical and dichotomous roles need to be intensively investigated. Current hypotheses identify as explanatory some critical factors, such as the type of the PnD biological products used or the manufacturing procedure to prepare the tissue\/cellular treatment, the experimental design (including human-relevant animal models), and intrinsic pathophysiological characteristics. The effective and safe translation of PnD treatments to clinical practice relies on the collaborative efforts of all researchers working with human-relevant oncological preclinical models. However, it requires proper guidelines and consensus compiled by experts and health workers who accurately describe the methodology of tissue collection, PnD isolation, manufacturing, preservation, and delivery to the final user.<\/jats:p>","DOI":"10.3390\/ijms23158570","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T21:41:37Z","timestamp":1659476497000},"page":"8570","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Application of Perinatal Derivatives on Oncological Preclinical Models: A Review of Animal Studies"],"prefix":"10.3390","volume":"23","author":[{"given":"Ricardo","family":"Teixo","sequence":"first","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment, Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Clinical Academic Center of Coimbra (CACC), 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7994-4650","authenticated-orcid":false,"given":"Ana Salom\u00e9","family":"Pires","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment, Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Clinical Academic Center of Coimbra (CACC), 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6532-2989","authenticated-orcid":false,"given":"Eurico","family":"Pereira","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment, Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Clinical Academic Center of Coimbra (CACC), 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3634-859X","authenticated-orcid":false,"given":"Beatriz","family":"Serambeque","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment, Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Clinical Academic Center of Coimbra (CACC), 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5690-3020","authenticated-orcid":false,"given":"In\u00eas Alexandra","family":"Marques","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment, Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Clinical Academic Center of Coimbra (CACC), 3000-548 Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-6007","authenticated-orcid":false,"given":"Mafalda","family":"Laranjo","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment, Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Clinical Academic Center of Coimbra (CACC), 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4399-6720","authenticated-orcid":false,"given":"Slavko","family":"Mojsilovi\u0107","sequence":"additional","affiliation":[{"name":"Group for Hematology and Stem Cells, Institute for Medical Research, University of Belgrade, 11129 Belgrade, Serbia"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3362-4170","authenticated-orcid":false,"given":"Roberto","family":"Gramignoli","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, 171 77 Stockholm, Sweden"},{"name":"Department of Pathology, Medicinsk Cancer Diagnostik, Karolinska University Hospital, 171 64 Huddinge, Sweden"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1892-6499","authenticated-orcid":false,"given":"Peter","family":"Ponsaerts","sequence":"additional","affiliation":[{"name":"Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (Vaxinfectio), University of Antwerp, 2610 Antwerp, Belgium"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6716-9551","authenticated-orcid":false,"given":"Andreina","family":"Schoeberlein","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Feto-Maternal Medicine, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland"},{"name":"Department for BioMedical Research (DBMR), University of Bern, 3012 Bern, Switzerland"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7202-1650","authenticated-orcid":false,"given":"Maria Filomena","family":"Botelho","sequence":"additional","affiliation":[{"name":"Coimbra Institute for Clinical and Biomedical Research (iCBR) Area of Environment, Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal"},{"name":"Clinical Academic Center of Coimbra (CACC), 3000-548 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"ref_2","unstructured":"World Health Organization (2020). WHO Report on Cancer: Setting Priorities, Investing Wisely and Providing Care for All, WHO."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101350","DOI":"10.1016\/j.jddst.2019.101350","article-title":"A concise review on cancer treatment methods and delivery systems","volume":"54","author":"Bidram","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4143\/crt.2022.078","article-title":"Challenges in the use of targeted therapies in non\u2013small cell lung cancer","volume":"54","author":"Uprety","year":"2022","journal-title":"Cancer Res. Treat."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3389\/fbioe.2021.742858","article-title":"Systematic review of the application of perinatal derivatives in animal models on cutaneous wound healing","volume":"9","author":"Pichlsberger","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"649446","DOI":"10.3389\/fbioe.2021.649446","article-title":"Case report: Freeze-dried human amniotic membrane allograft for the treatment of chronic wounds: Results of a multicentre observational study","volume":"9","author":"Schmiedova","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"649317","DOI":"10.3389\/fbioe.2021.649317","article-title":"Case report: Wound closure acceleration in a patient with toxic epidermal necrolysis using a lyophilised amniotic membrane","volume":"9","author":"Forostyak","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"689328","DOI":"10.3389\/fbioe.2021.689328","article-title":"Chronic wound healing by amniotic membrane: TGF-\u03b2 and EGF signaling modulation in re-epithelialization","volume":"9","author":"Liarte","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0963689717738256","article-title":"Extracellular vesicles derived from Wharton\u2019s jelly mesenchymal stem cells prevent and resolve programmed cell death mediated by perinatal hypoxia-ischemia in neuronal cells","volume":"27","author":"Oppliger","year":"2018","journal-title":"Cell Transplant."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"619980","DOI":"10.3389\/fbioe.2020.619980","article-title":"Perinatal Cells: A promising COVID-19 therapy?","volume":"8","author":"Papait","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"811875","DOI":"10.3389\/fbioe.2022.811875","article-title":"Application of perinatal derivatives in ovarian diseases","volume":"10","author":"Capra","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Thomi, G., Joerger-Messerli, M., Haesler, V., Muri, L., Surbek, D., and Schoeberlein, A. (2019). Intranasally administered exosomes from umbilical cord stem cells have preventive neuroprotective effects and contribute to functional recovery after perinatal brain injury. Cells, 8.","DOI":"10.3390\/cells8080855"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fbioe.2021.661332","article-title":"Use of amniotic membrane and its derived products for bone regeneration: A systematic review","volume":"9","author":"Etchebarne","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fphys.2018.00385","article-title":"Cardiac restoration stemming from the placenta tree: Insights from fetal and perinatal cell biology","volume":"9","author":"Bollini","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10561-017-9618-5","article-title":"Amniotic membrane in ophthalmology: Properties, preparation, storage and indications for grafting\u2014a review","volume":"18","author":"Jirsova","year":"2017","journal-title":"Cell Tissue Bank."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Costa, E., and Murta, J.N. (2015). Amniotic membrane in ophthalmology. Amniotic Membrane: Origin, Characterization and Medical Applications, Springer.","DOI":"10.1007\/978-94-017-9975-1_6"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.placenta.2017.05.011","article-title":"The dichotomy of placenta-derived cells in cancer growth","volume":"59","author":"Silini","year":"2017","journal-title":"Placenta"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Mamede, A.C., Pires, A.S., and Brito, A.F. (2015). Amniotic membrane in cancer. Amniotic Membrane: Origin Characterization and Medical Applications, Springer.","DOI":"10.1007\/978-94-017-9975-1"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/neuonc\/nor204","article-title":"Stem cells as therapeutic vehicles for the treatment of high-grade gliomas","volume":"14","author":"Binello","year":"2012","journal-title":"Neuro-Oncology"},{"key":"ref_22","first-page":"441","article-title":"Isolation and characterization of stem cells from the placenta and the umbilical cord","volume":"49","author":"Mihu","year":"2008","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3892\/ol.2012.772","article-title":"Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model","volume":"4","author":"Chen","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.2147\/CMAR.S209880","article-title":"Anti-tumor effects of engineered mesenchymal stem cells in colon cancer model","volume":"11","author":"Yang","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canlet.2009.02.011","article-title":"Na\u00efve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo","volume":"280","author":"Ayuzawa","year":"2009","journal-title":"Cancer Lett."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ohta, N., Ishiguro, S., Kawabata, A., Uppalapati, D., Pyle, M., Troyer, D., De, S., Zhang, Y., Becker, K.G., and Tamura, M. (2015). Human umbilical cord matrix mesenchymal stem cells suppress the growth of breast cancer by expression of tumor suppressor genes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123756"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"610544","DOI":"10.3389\/fbioe.2020.610544","article-title":"Perinatal derivatives: Where do we stand? A roadmap of the human placenta and consensus for tissue and cell nomenclature","volume":"8","author":"Silini","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.actbio.2016.01.017","article-title":"Decidua-derived mesenchymal stem cells as carriers of mesoporous silica nanoparticles. In vitro and in vivo evaluation on mammary tumors","volume":"33","author":"Paris","year":"2016","journal-title":"Acta Biomater."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/cgt.2012.71","article-title":"Decidua mesenchymal stem cells migrated toward mammary tumors in vitro and in vivo affecting tumor growth and tumor development","volume":"20","author":"Vegh","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/s12935-021-02300-4","article-title":"Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance","volume":"21","author":"Xuan","year":"2021","journal-title":"Cancer Cell Int."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pires, S., Bollini, S., Botelho, M.F., Lang-Olip, I., Ponsaerts, P., Balbi, C., Lange-Consiglio, A., F\u00e9nelon, M., Mojsilovi\u0107, S., and Cremonesi, F. (2022). Guidelines to analyse preclinical studies using perinatal derivatives. IRIS Inst. Res. Inf. Syst., 1\u201332.","DOI":"10.3390\/mps6030045"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"675443","DOI":"10.3389\/fphar.2021.675443","article-title":"Rejuvenation of Helicobacter pylori\u2013Associated atrophic gastritis through concerted actions of placenta-derived mesenchymal stem cells prevented gastric cancer","volume":"12","author":"Park","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1002\/jcp.30080","article-title":"IL-8\/CXCR2 mediates tropism of human bone marrow-derived mesenchymal stem cells toward CD133+ \/CD44+ colon cancer stem cells","volume":"236","author":"Ma","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"ref_34","first-page":"1627","article-title":"Characterization and validation of hepatocellular carcinoma (HCC) xenograft tumor as a suitable liver cancer model for preclinical mesenchymal stem cell studies","volume":"19","author":"Hajighasemlou","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S448","DOI":"10.1080\/21691401.2018.1499661","article-title":"MRI tracking of polyethylene glycol-coated superparamagnetic iron oxide-labelled placenta-derived mesenchymal stem cells toward glioblastoma stem-like cells in a mouse model","volume":"46","author":"Hsu","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zheng, L., Zhang, D., Chen, X., Yang, L., Wei, Y., and Zhao, X. (2012). Antitumor activities of human placenta-derived mesenchymal stem cells expressing endostatin on ovarian cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039119"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7150\/ijms.8758","article-title":"Suppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer","volume":"11","author":"Zhang","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.1002\/jcp.27637","article-title":"Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma","volume":"234","author":"Seyhoun","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S1011","DOI":"10.1080\/21691401.2018.1527345","article-title":"Anti-tumour effects of TRAIL-expressing human placental derived mesenchymal stem cells with curcumin-loaded chitosan nanoparticles in a mice model of triple negative breast cancer","volume":"46","author":"Farahani","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41598-017-18428-1","article-title":"Human placental-derived adherent stromal cells co-induced with TNF-\u03b1 and IFN-\u03b3 inhibit triple-negative breast cancer in nude mouse xenograft models","volume":"8","author":"Allen","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/gt.2015.90","article-title":"The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth","volume":"23","author":"Li","year":"2016","journal-title":"Gene Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/cgt.2012.15","article-title":"Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models","volume":"19","author":"Kang","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/mt.2011.28","article-title":"hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence","volume":"19","author":"Yin","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4592701","DOI":"10.1155\/2019\/4592701","article-title":"The different effects of IFN-\u03b2 and IFN-\u03b3 on the tumor-suppressive activity of human amniotic fluid-derived mesenchymal stem cells","volume":"2019","author":"Du","year":"2019","journal-title":"Stem Cells Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1089\/scd.2011.0151","article-title":"Human amniotic fluid-derived mesenchymal stem cells as therapeutic vehicles: A novel approach for the treatment of bladder cancer","volume":"21","author":"Bitsika","year":"2012","journal-title":"Stem Cells Dev."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Li, L., Wang, D., Zhou, J., Cheng, Y., Liang, T., and Zhang, G. (2015). Characteristics of human amniotic fluid mesenchymal stem cells and their tropism to human ovarian cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123350"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.3892\/mmr.2015.4076","article-title":"Effect of targeted ovarian cancer therapy using amniotic fluid mesenchymal stem cells transfected with enhanced green fluorescent protein-human interleukin-2 in vivo","volume":"12","author":"You","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1241323","DOI":"10.1155\/2018\/1241323","article-title":"IFN\u03b1-expressing amniotic fluid-derived mesenchymal stem cells migrate to and suppress HeLa cell-derived tumors in a mouse model","volume":"2018","author":"Zhou","year":"2018","journal-title":"Stem Cells Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3892\/ijo.2017.4123","article-title":"Human amniotic epithelial cells inhibit growth of epithelial ovarian cancer cells via TGF-\u03b21-mediated cell cycle arrest","volume":"51","author":"Bu","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/ijc.31159","article-title":"Vaccination with human amniotic epithelial cells confer effective protection in a murine model of Colon adenocarcinoma","volume":"142","author":"Tabatabaei","year":"2018","journal-title":"Int. J. Cancer"},{"key":"ref_51","first-page":"2022","article-title":"Human amniotic membrane-derived epithelial stem cells display anticancer activity in BALB\/c female nude mice bearing disseminated breast cancer xenografts","volume":"40","author":"Kang","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"39051","DOI":"10.18632\/oncotarget.9694","article-title":"Conditioned medium derived from rat amniotic epithelial cells confers protection against inflammation, cancer, and senescence","volume":"7","author":"Bernier","year":"2016","journal-title":"Oncotarget"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11033-011-0760-z","article-title":"Human amniotic membrane derived-mesenchymal stem cells induce C6 glioma apoptosis in vivo through the Bcl-2\/caspase pathways","volume":"39","author":"Jiao","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12032-015-0702-z","article-title":"Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma","volume":"32","author":"Mamede","year":"2015","journal-title":"Med. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Yun, J.W., Ahn, J.H., Kwon, E., Kim, S.H., Kim, H., Jang, J.J., Kim, W.H., Kim, J.H., Han, S.Y., and Kim, J.T. (2016). Human Umbilical Cord-Derived Mesenchymal Stem Cells in Acute Liver Injury: Hepatoprotective Efficacy, Subchronic Toxicity, Tumorigenicity, and Biodistribution, Elsevier Ltd.","DOI":"10.1016\/j.yrtph.2016.09.029"},{"key":"ref_56","first-page":"2093","article-title":"Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo","volume":"8","author":"Fan","year":"2013","journal-title":"Neural Regen. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1016\/j.biomaterials.2014.03.014","article-title":"Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy","volume":"35","author":"Leng","year":"2014","journal-title":"Biomaterials"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1089\/scd.2014.0254","article-title":"A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression","volume":"24","author":"Ciavarella","year":"2015","journal-title":"Stem Cells Dev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/sj.cgt.7701077","article-title":"Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors","volume":"14","author":"Rachakatla","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.3727\/096368915X687462","article-title":"Human umbilical cord mesenchymal stem cells promote breast cancer metastasis by interleukin-8- and interleukin-6-dependent induction of CD44+\/CD24\u2212 cells","volume":"24","author":"Ma","year":"2015","journal-title":"Cell Transplant."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10549-011-1774-x","article-title":"The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells","volume":"133","author":"Ma","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/21691401.2018.1434185","article-title":"Nano-loaded human umbilical cord mesenchymal stem cells as targeted carriers of doxorubicin for breast cancer therapy","volume":"46","author":"Cao","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Di, G.-H., Liu, Y., Lu, Y., Liu, J., Wu, C., and Duan, H.-F. (2014). IL-6 Secreted from senescent mesenchymal stem cells promotes proliferation and migration of breast cancer cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113572"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3892\/ijmm.2014.2019","article-title":"Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells","volume":"35","author":"Wang","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_65","first-page":"370","article-title":"Fusion of human umbilical cord mesenchymal stem cells with esophageal carcinoma cells inhibits the tumorigenicity of esophageal carcinoma cells","volume":"40","author":"Lu","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Xue, J., Zhu, Y., Sun, Z., Ji, R., Zhang, X., Xu, W., Yuan, X., Zhang, B., Yan, Y., and Yin, L. (2015). Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1780-1"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Liu, J., Han, G., Liu, H., and Qin, C. (2013). Suppression of cholangiocarcinoma cell growth by human umbilical cord mesenchymal stem cells: A possible role of Wnt and Akt signaling. PLoS ONE, 8.","DOI":"10.1371\/annotation\/7fff93fa-8e80-41f3-b35a-e658cb7256a9"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"42276","DOI":"10.18632\/oncotarget.5514","article-title":"Involvement of Wnt\/\u03b2-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.biomaterials.2013.12.037","article-title":"Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter","volume":"35","author":"Yan","year":"2014","journal-title":"Biomaterials"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1021\/mp300261e","article-title":"Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: A double-target therapy against non-Hodgkin\u2019s lymphoma","volume":"10","author":"Yan","year":"2013","journal-title":"Mol. Pharm."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13287-017-0655-6","article-title":"pIL6-TRAIL-engineered umbilical cord mesenchymal\/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo","volume":"8","author":"Cafforio","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2147\/OTT.S147855","article-title":"IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt\/\u03b2-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer","volume":"11","author":"Zhang","year":"2018","journal-title":"OncoTargets Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/jcp.29095","article-title":"Umbilical cord-derived mesenchymal stromal\/stem cells expressing IL-24 induce apoptosis in gliomas","volume":"235","author":"Fan","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13045-017-0397-z","article-title":"Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3\/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor d-1-methyl-tryptophan","volume":"10","author":"Zhang","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lungcan.2010.01.003","article-title":"Human umbilical cord matrix-derived stem cells expressing interferon-\u03b2 gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice","volume":"70","author":"Matsuzuka","year":"2010","journal-title":"Lung Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00432-019-02859-6","article-title":"Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo","volume":"145","author":"Meng","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3109\/14653249.2011.646044","article-title":"Human umbilical cord mesenchymal stromal cells mitigate chemotherapy-associated tissue injury in a pre-clinical mouse model","volume":"14","author":"Di","year":"2012","journal-title":"Cytotherapy"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41419-018-0323-5","article-title":"Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR-410","volume":"9","author":"Dong","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"591","DOI":"10.18632\/oncotarget.22712","article-title":"Nicotine-enhanced stemness and epithelial-mesenchymal transition of human umbilical cord mesenchymal stem cells promote tumor formation and growth in nude mice","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8425","DOI":"10.1007\/s13277-015-4746-7","article-title":"Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1\/CCR2 axis and exhibit antitumor effects","volume":"37","author":"Yan","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.rbmo.2011.10.007","article-title":"Extra-embryonic human Wharton\u2019s jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells","volume":"24","author":"Gauthaman","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jcb.24367","article-title":"Human Wharton\u2019s jelly stem cell conditioned medium and cell-free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice","volume":"114","author":"Gauthaman","year":"2013","journal-title":"J. Cell. Biochem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.yexcr.2016.06.003","article-title":"Wharton\u2019s jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer","volume":"345","author":"Vulcano","year":"2016","journal-title":"Exp. Cell Res."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Wu, S., Ju, G.-Q., Du, T., Zhu, Y.-J., and Liu, G.-H. (2013). Microvesicles derived from human umbilical cord Wharton\u2019s jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061366"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Du, T., Ju, G., Wu, S., Cheng, Z., Cheng, J., Zou, X., Zhang, G., Miao, S., Liu, G., and Zhu, Y. (2014). Microvesicles derived from human Wharton\u2019s jelly mesenchymal stem cells promote human renal cancer cell growth and aggressiveness through induction of hepatocyte growth factor. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096836"},{"key":"ref_86","first-page":"945","article-title":"Human Wharton\u2019s jelly mesenchymal stem cells-derived secretome could inhibit breast cancer growth in vitro and in vivo","volume":"23","author":"Mirabdollahi","year":"2020","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1021\/acsami.9b19054","article-title":"Human umbilical cord Wharton\u2019s jelly-derived mesenchymal stem cells labeled with Mn2+ and Gd3+ co-doped CuInS2\u2013ZnS nanocrystals for multimodality imaging in a tumor mice model","volume":"12","author":"Chetty","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_88","first-page":"353","article-title":"Impact of mesenchymal stem cells\u2019 secretome on glioblastoma pathophysiology","volume":"15","author":"Gomes","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.semcancer.2021.03.032","article-title":"Exosomes and extracellular vesicles: Rethinking the essential values in cancer biology","volume":"74","author":"Yokoi","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"411","DOI":"10.7150\/thno.33482","article-title":"Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/10799893.2021.1918166","article-title":"MicroRNA-320a-containing exosomes from human umbilical cord mesenchymal stem cells curtail proliferation and metastasis in lung cancer by binding to SOX4","volume":"42","author":"Xie","year":"2021","journal-title":"J. Recept. Signal Transduct."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13046-020-01631-w","article-title":"Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression","volume":"39","author":"He","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41388-020-01486-7","article-title":"Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1","volume":"40","author":"Jia","year":"2021","journal-title":"Oncogene"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3389\/fonc.2019.01076","article-title":"Exosomes derived from microRNA-148b-3p-overexpressing human umbilical cord mesenchymal stem cells restrain breast cancer progression","volume":"9","author":"Yuan","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12967-021-03226-1","article-title":"MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K\/AKT pathway in papillary thyroid carcinoma","volume":"20","author":"Zheng","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.7150\/thno.30030","article-title":"Biodistribution of gadolinium- and near infrared-labeled human umbilical cord mesenchymal stromal cell-derived exosomes in tumor bearing mice","volume":"9","author":"Abello","year":"2019","journal-title":"Theranostics"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.canlet.2018.10.039","article-title":"Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression","volume":"442","author":"Ding","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"679185","DOI":"10.3389\/fcell.2021.679185","article-title":"miR-224-5p carried by human umbilical cord mesenchymal stem cells-derived exosomes regulates autophagy in breast cancer cells via HOXA5","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"101623","DOI":"10.1016\/j.tice.2021.101623","article-title":"Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p","volume":"73","author":"Ding","year":"2021","journal-title":"Tissue Cell"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1007\/s00432-021-03684-6","article-title":"Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C","volume":"147","author":"Liu","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_101","first-page":"89","article-title":"Revisiting colorectal cancer animal model\u2014An improved metastatic model for distal rectosigmoid colon carcinoma","volume":"25","author":"Gomes","year":"2018","journal-title":"Pathophysiology Off. J. Soc. Pathophysiol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Mendes, N., Carvalho, P.D., Martins, F., Mendon\u00e7a, S., Malheiro, A.R., Ribeiro, A., Carvalho, J., and Velho, S. (2020). Animal Models to Study Cancer and Its Microenvironment, Springer.","DOI":"10.1007\/978-3-030-34025-4_20"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2147\/DDDT.S49584","article-title":"Animal models and therapeutic molecular targets of cancer: Utility and limitations","volume":"8","author":"Cekanova","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Harper, K., Yatsyna, A., Charbonneau, M., Brochu-Gaudreau, K., Perreault, A., Jeldres, C., McDonald, P.P., and Dubois, C.M. (2021). The chicken chorioallantoic membrane tumor assay as a relevant in vivo model to study the impact of hypoxia on tumor progression and metastasis. Cancers, 13.","DOI":"10.3390\/cancers13051093"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8570\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:01:09Z","timestamp":1760140869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,2]]},"references-count":104,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23158570"],"URL":"https:\/\/doi.org\/10.3390\/ijms23158570","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2022,8,2]]}}}